CORRECTING and REPLACING Viropro Postpones Stockholders Meeting
26 Julio 2011 - 10:16PM
Business Wire
Please replace the release with the following corrected version
due to multiple revisions to headline and text.
The corrected release reads:
VIROPRO POSTPONES STOCKHOLDERS
MEETING
VIROPRO (PK: VPRO) announces that the
stockholders meeting scheduled for July 28, 2011 is postponed until
after Audited Financial Statements are available. Postponement of
meeting does not prevent Viropro from carrying on its operations as
usual.
About Viropro, Inc.:
Viropro, Inc. conducts operations through its subsidiaries
Viropro International Inc., and Biologics Process Development, Inc.
and specializes in the transfer of its technologies for industrial
production of biopharmaceutical therapeutic proteins for the
treatment of various diseases including cancer, diabetes, hepatitis
and multiple sclerosis. The Company’s principal objective is to
provide its high-yield manufacturing process technology to
biopharmaceutical companies in global markets with unmet medical
and/or market needs. (www.viropro.com)
Viropro Inc. Safe Harbor Statement
Except for any historic information contained herein, the
matters discussed in this press release contain forward-looking
statements that involve risks and uncertainties, which are subject
to section 27A of the Securities Act of 1933 and section 21E of the
Exchange Act of 1934, and are subject to safe harbor created by
these sections. Any statements that express or involve discussions
with respect to predictions, beliefs, plans, projections,
objectives, goals, assumptions of future events or performances are
not statements of historical fact and may be "forward-looking
statements". Forward-looking statements in this release may be
identified through the use of such words as "expects",
"anticipates", "estimates", "believes", or statements indicating
certain actions "may", "could", or "might" occur. Actual results,
performance or achievements could differ materially from those
anticipated in such forward-looking statements, which involve
numerous risks and uncertainties, including the Company's ability
to market its products and services in a competitive environment as
well as other factors.
Viropro (CE) (USOTC:VPRO)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Viropro (CE) (USOTC:VPRO)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024
Real-Time news about Viropro Inc (CE) (OTCMarkets): 0 recent articles
Más de Viropro, Inc. Artículos de Noticias